Navigation Links
China Sky One Medical Inc. Gets SFDA Approval for Calcium Folinate Injection

HARBIN, China, March 3 /PRNewswire-Asia-FirstCall/ -- China Sky One Medical, Inc. ("China Sky One Medical" or "the Company") (Nasdaq: CSKI), a leading fully integrated pharmaceutical company producing over-the-counter drugs in the People's Republic of China ("PRC"), today announced that it obtained production approval from the State Food and Drug Administration (SFDA) in China for Calcium Folinate Injection. Another two new traditional Chinese medicines, Paeonol gel and Mei Lu gel, were approved by SFDA to enter into clinical trials. All three are all prescription drugs.

Calcium Folinate Injection is a solution for injection intended as an auxiliary therapy for sprue (a disease of the small intestine), malnutrition, pregnancy- or infancy-related megaloblastic anemia, and colonic and rectal cancer. It will be available to consumers around June of 2009.

Paeonol gel is a type of anti-allergic, anti-pyretic and anti-itch medicine that can be used for the treatment of eczema, dermatitis and other kinds of skin diseases caused by insect bites. It can also be used to cure allergic rhinitis as well as for the prevention of colds. Mei Lu gel is used to treat Acne vulgaris and to relieve itching. It can also be used to cure other skin diseases, including eczema and dermatitis solaris, and repel insects. Clinical trials for the two gels will last approximately six months, and management expects to receive final SFDA approvals in 2010.

"We are very pleased to achieve such great progress in developing new drugs," said Mr. Yan-Qing Liu, Chairman and CEO of China Sky One Medical. "All of these products have been developed to meet customers' needs. We expect them to perform well and to create value for consumers and shareholders alike."

About China Sky One Medical, Inc.

China Sky One Medical, Inc., a Nevada corporation, is a holding company. The Company engages in the manufacturing, marketing and distribution of pharmaceutical, medicinal and diagnostic products. Through its wholly-owned subsidiaries, Harbin Tian Di Ren Medical Science and Technology Company ("TDR"), Harbin First Bio-Engineering Company Limited ("First"), Heilongjiang Tianlong Pharmaceutical, Inc. ("Tianlong") and Peng Lai Jin Chuang Pharmaceutical Company ("Jin Chuang") the Company manufactures and distributes over-the-counter pharmaceutical products, which make up its major revenue source. For more information, visit .

Safe Harbor Statement

Certain of the statements made in the press release constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements can be identified by the use of forward-looking terminology such as "believe," "expect," "may," "will," "should," "project," "plan," "seek," "intend," or "anticipate" or the negative thereof or comparable terminology. Such statements typically involve risks and uncertainties and may include financial projections or information regarding the progress of new product development. Actual results could differ materially from the expectations reflected in such forward-looking statements as a result of a variety of factors, including the risks associated with the effect of changing economic conditions in The People's Republic of China, variations in cash flow, reliance on collaborative retail partners and on new product development, variations in new product development, risks associated with rapid technological change, and the potential of introduced or undetected flaws and defects in products, and other risk factors detailed in reports filed with the Securities and Exchange Commission from time to time.

    For more information, please contact:

    Company Contact:
     China Sky One Medical, Inc.
     Mr. Yu-Bo Hao, CFO
     Tel:   +86-451-5399-4069

    Investor Relations Contact:
     CCG Investor Relations
     Mr. Crocker Coulson, President
     Tel:   +1-646-213-1915

SOURCE China Sky One Medical Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. China Nepstar Chain Drugstore to Announce Fourth Quarter and Fiscal 2008 Financial Results on March 16
2. University of the Rockies Faculty and Students Travel to China to Share Western Philosophy
3. QSAI & SGS-CSTC to Begin Joint Food Analysis Services in China
4. China Sky One Medical, Inc. Exports Sumei Slim Patch to South Korea and Sudan
5. China Healthcare Acquisition Announces Record Date for Trust Fund Distribution
6. Hard To Treat Diseases (HTDS) Closes Acquisition of Mellow Hope, China
7. China YCT International Group, Inc. Announces Third Quarter Fiscal 2009 Results
8. China Shenghuo Receives Notice from NYSE Alternext US Regarding Listing Standards
9. China-Biotics, Inc. Reports Third Quarter 2009 Financial Results
10. Senator James Sasser, Former Ambassador to China, Joins Neuralstem Advisory Board
11. China-Biotics, Inc. Announces Conference Call to Discuss Third Quarter 2009 Financial Results
Post Your Comments:
(Date:11/28/2015)... (PRWEB) , ... November 28, 2015 , ... Trying to ... has created the COUCH BUDDY. "I conceived of this design due to personal experience ... for couch users. It promotes relaxation and convenience, as well as increases support. It ...
(Date:11/28/2015)... ... ... Pixel Film Studios is back again with ProPanel: Pulse . With ... Users have full control over angle of view, speed method, start point, end point, ... get heads to turn. , ProPanel: Pulse offers fully customizable pulsating shape masks, all ...
(Date:11/27/2015)... , ... November 27, 2015 , ... According to an ... recent 2015 American Dental Association meeting in Washington D.C. revolved around the fact that ... patient’s overall health. The talk stressed the link between periodontal disease (more commonly referred ...
(Date:11/27/2015)... ... November 27, 2015 , ... According to an ... changing the way that they are handling security in light of the recent terrorist ... presence in an attempt to stop an attack from reaching U.S. soil. Especially around ...
(Date:11/27/2015)... NC (PRWEB) , ... November 27, 2015 , ... A ... effective ways to treat it. Surviving Mesothelioma has just posted the findings on ... at University Hospital Zurich analyzed the cases of 136 mesothelioma patients who were treated ...
Breaking Medicine News(10 mins):
(Date:11/27/2015)... YORK , November 27, 2015 ... system is set to go online. The potential to ... processes is vast and far from fully exploited as ... to patient health records, either via mobile tablet or ... ) --> ) --> ...
(Date:11/27/2015)... ) ... "2016 Global Tumor Marker Testing Market: Supplier ... Segment Forecasts, Innovative Technologies, Instrumentation Review, Competitive ... offering. --> ) has ... Global Tumor Marker Testing Market: Supplier Shares ...
(Date:11/26/2015)... Netherlands , November 26, 2015 ... A new combination approach blends immunotherapy with Bremachlorin-photodynamic ... A new combination approach blends immunotherapy with Bremachlorin-photodynamic therapy ... A new combination approach blends immunotherapy with Bremachlorin-photodynamic therapy ... Netherlands has found that immunotherapy can be ...
Breaking Medicine Technology: